Celon Pharma
CLN.WA
#7260
Rank
A$0.52 B
Marketcap
$9.78
Share price
-2.25%
Change (1 day)
76.86%
Change (1 year)

Revenue for Celon Pharma (CLN.WA)

Revenue in 2024 (TTM): A$63.67 Million

According to Celon Pharma's latest financial reports the company's current revenue (TTM ) is A$65.2 Million. In 2023 the company made a revenue of A$57.99 Million an increase over the revenue in the year 2022 that were of A$53.2 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Celon Pharma from 2016 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) A$63.67 M9.78%
2023 A$57.99 M9.01%
2022 A$53.2 M-10.34%
2021 A$59.34 M28.15%
2020 A$46.3 M21.7%
2019 A$38.05 M-21.79%
2018 A$48.65 M31.12%
2017 A$37.1 M-25.45%
2016 A$49.77 M